To our knowledge, POLG mutations are mostly used for diagnostic purposes and are currently not a therapeutic target; however, patients with POLG1 parkinsonism seem to respond to levodopa treatment for a sustained period of time [157,183]. This evidence concerns the gene POLG and Parkinsonism.